ArticleBMC cancer2019

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.

Feng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.